Study #2024-0094
NCI PBTC-061 - Phase 2 trial of G207 + 5 Gy radiation for children with High-Grade Gliomas
MD Anderson Study Status
Enrolling
Treatment Agent
Biological G207
Description
This study is a clinical trial to assess the efficacy and confirm the safety of intratumoral inoculation of G207 (an experimental virus therapy) combined with a single 5 Gy dose of radiation in recurrent/progressive pediatric high-grade gliomas
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Neoplasms, High Grade Glioma, Glioblastoma Multiforme, Malignant Glioma of Brain, Anaplastic Astrocytoma of Brain, High-grade Glioma, Anaplastic Glioma, Giant Cell Glioblastoma
Study phase:
Phase II
Physician name:
Gregory Friedman
Department:
Pediatrics
For general questions about clinical trials:
1-844-897-9044
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.